KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Preferred Shares: 2011

Historic Preferred Shares for Supernus Pharmaceuticals (SUPN) over the last 1 years, with Dec 2011 value amounting to $49,000.

  • Supernus Pharmaceuticals' Preferred Shares was N/A to $49,000 in Q1 2012 from the same period last year, while for Mar 2012 it was $49,000, marking a year-over-year change of. This contributed to the annual value of $49,000 for FY2011, which is N/A change from last year.
  • According to the latest figures from FY2011, Supernus Pharmaceuticals' Preferred Shares is $49,000.
  • In the past 5 years, Supernus Pharmaceuticals' Preferred Shares registered a high of $49,000 during FY2011, and its lowest value of $49,000 during FY2011.
  • Its 1-year average for Preferred Shares is $49,000, with a median of $49,000 in 2011.